PPA
VIRX

Parametric Portfolio Associates’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Parametric Portfolio Associates’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$115K Buy
+24,129
New +$72.7K ﹤0.01% 3543
2015
Q3 		– Sell
-222
Closed -$140K – 3343
2015
Q2 		$140K Sell
222
-6
-3% -$3.19K ﹤0.01% 3831
2015
Q1 		$117K Sell
228
-24
-10% -$12.1K ﹤0.01% 3842
2014
Q4 		$135K Sell
252
-43
-15% -$19.4K ﹤0.01% 3866
2014
Q3 		$443K Buy
295
+6
+2% +$8.69K ﹤0.01% 3267
2014
Q2 		$396K Buy
289
+45
+18% +$52.2K ﹤0.01% 3360
2014
Q1 		$338K Buy
244
+91
+59% +$106K ﹤0.01% 3379
2013
Q4 		$152K Buy
153
+3
+2% +$3.1K ﹤0.01% 3678
2013
Q3 		$156K Buy
+150
New +$160K ﹤0.01% 3659

Other funds holding VIRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.6B AUM 18.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return